Doctors Lax in Monitoring Potentially Addicting Drugs
By HospiMedica International staff writers Posted on 14 Mar 2011 |
A new study claims that few primary care physicians pay adequate attention to patients taking prescription opioid drugs for chronic noncancer pain (CNCP), despite the potential for abuse, addiction, and overdose.
Researchers at Yeshiva University (YU; New York, NY, USA) conducted a retrospective cohort study using electronic medical records (EMRs) of 1,612 patients on long-term opioids treated for CNCP in eight primary care practices. The researchers examined three risk reduction strategies: urine drug tests; regular office visits (at least once per 6 months and within 30 days of modifying opioid treatment); and restricted early refills (one or fewer opioid refills more than a week early). Associations of risk factors with each outcome were assessed in mixed-effects models, adjusting for patient clustering within physicians, demographics, and clinical factors.
The results showed that only a small minority (8%) of patients were found to have undergone any urine drug testing. While such testing was more common in patients at higher risk for opioid misuse, the rate of testing among those high-risk patients was still low (24%). Only half of the patients were seen regularly in the office, and patients at higher risk of opioid misuse were not seen more frequently than patients at lower risk were. Although only 23% of all patients received two or more early opioid refills, patients at greater risk for opioid misuse were more likely to receive multiple early refills. An increasing number of risk factors was positively associated with urine drug testing, but negatively associated with restricted early refills. The study was published in the March 2, 2011, online edition of the Journal of General Internal Medicine.
"We were disturbed to find that patients with a drug use disorder were seen less frequently in the office and were prescribed more early refills than patients without these disorders,” said lead author Joanna Starrels, MD, MS, an assistant professor of medicine at the YU Albert Einstein College of Medicine. "The finding that physicians did not increase precautions for patients at highest risk for opioid misuse should be a call for a standardized approach to monitoring.”
Prescription drug misuse is a major public health problem. An estimated 48 million people over the age of 12 in the United States have taken prescription drugs for nonmedical uses in their lifetime, which represents approximately 20% of the US population. Opioids, central nervous system depressants, and stimulants were the drugs most commonly abused.
Related Links:
Yeshiva University
Researchers at Yeshiva University (YU; New York, NY, USA) conducted a retrospective cohort study using electronic medical records (EMRs) of 1,612 patients on long-term opioids treated for CNCP in eight primary care practices. The researchers examined three risk reduction strategies: urine drug tests; regular office visits (at least once per 6 months and within 30 days of modifying opioid treatment); and restricted early refills (one or fewer opioid refills more than a week early). Associations of risk factors with each outcome were assessed in mixed-effects models, adjusting for patient clustering within physicians, demographics, and clinical factors.
The results showed that only a small minority (8%) of patients were found to have undergone any urine drug testing. While such testing was more common in patients at higher risk for opioid misuse, the rate of testing among those high-risk patients was still low (24%). Only half of the patients were seen regularly in the office, and patients at higher risk of opioid misuse were not seen more frequently than patients at lower risk were. Although only 23% of all patients received two or more early opioid refills, patients at greater risk for opioid misuse were more likely to receive multiple early refills. An increasing number of risk factors was positively associated with urine drug testing, but negatively associated with restricted early refills. The study was published in the March 2, 2011, online edition of the Journal of General Internal Medicine.
"We were disturbed to find that patients with a drug use disorder were seen less frequently in the office and were prescribed more early refills than patients without these disorders,” said lead author Joanna Starrels, MD, MS, an assistant professor of medicine at the YU Albert Einstein College of Medicine. "The finding that physicians did not increase precautions for patients at highest risk for opioid misuse should be a call for a standardized approach to monitoring.”
Prescription drug misuse is a major public health problem. An estimated 48 million people over the age of 12 in the United States have taken prescription drugs for nonmedical uses in their lifetime, which represents approximately 20% of the US population. Opioids, central nervous system depressants, and stimulants were the drugs most commonly abused.
Related Links:
Yeshiva University
Latest Critical Care News
- Novel Cannula Delivery System Enables Targeted Delivery of Imaging Agents and Drugs
- Ingestible Smart Capsule for Chemical Sensing in the Gut Moves Closer to Market
- Novel Intrabronchial Method Delivers Cell Therapies in Critically Ill Patients on External Lung Support
- Generative AI Technology Detects Heart Disease Earlier Than Conventional Methods
- Wearable Technology Predicts Cardiovascular Risk by Continuously Monitoring Heart Rate Recovery
- Wearable Health Monitoring Device Measures Gases Emitted from and Absorbed by Skin
- Groundbreaking Technology Rapidly Detects Airborne Influenza Viruses
- Handheld Device Could Transform Heart Disease Screening
- Flexible Semi-Autonomous Robot Could Deliver Medicine Inside Body
- Neurorestorative Treatment Strategies Hold Promise for Most Severe Forms of Epilepsy
- Gene Discovery Could Help Grow New Heart Arteries
- Study Discovers Invisible Transmission of Common Hospital-Associated Infection
- Non-Invasive Neuro-Ophthalmology Techniques Could Detect Brain Tumors Earlier
- Mass Manufactured Nanoparticles to Deliver Cancer Drugs Directly to Tumors
- World’s Smallest Pacemaker Fits Inside Syringe Tip
- AI-Powered, Internet-Connected Medical Devices to Revolutionize Healthcare, Finds Study
Channels
Surgical Techniques
view channel
Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures
In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more
Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures
Patients diagnosed with coronary artery disease, which is caused by plaque accumulation within the arteries leading to chest pain, shortness of breath, and potential heart attacks, frequently undergo percutaneous... Read more
World's First AI Surgical Guidance Platform Allows Surgeons to Measure Success in Real-Time
Surgeons have always faced challenges in measuring their progress toward surgical goals during procedures. Traditionally, obtaining measurements required stepping out of the sterile environment to perform... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more